Lipid droplets and ferritin heavy chain: a devilish liaison in human cancer cell radioresistance
Although much progress has been made in cancer treatment, the molecular mechanisms underlying cancer radioresistance (RR) as well as the biological signatures of radioresistant cancer cells still need to be clarified. In this regard, we discovered that breast, bladder, lung, neuroglioma, and prostat...
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
eLife Sciences Publications Ltd
2021-09-01
|
Series: | eLife |
Subjects: | |
Online Access: | https://elifesciences.org/articles/72943 |
id |
doaj-875cfacd9fc346f3be09bad933aa1257 |
---|---|
record_format |
Article |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Luca Tirinato Maria Grazia Marafioti Francesca Pagliari Jeannette Jansen Ilenia Aversa Rachel Hanley Clelia Nisticò Daniel Garcia-Calderón Geraldine Genard Joana Filipa Guerreiro Francesco Saverio Costanzo Joao Seco |
spellingShingle |
Luca Tirinato Maria Grazia Marafioti Francesca Pagliari Jeannette Jansen Ilenia Aversa Rachel Hanley Clelia Nisticò Daniel Garcia-Calderón Geraldine Genard Joana Filipa Guerreiro Francesco Saverio Costanzo Joao Seco Lipid droplets and ferritin heavy chain: a devilish liaison in human cancer cell radioresistance eLife lipid droplets radioresistance iron metabolism ferritin heavy chain cancer |
author_facet |
Luca Tirinato Maria Grazia Marafioti Francesca Pagliari Jeannette Jansen Ilenia Aversa Rachel Hanley Clelia Nisticò Daniel Garcia-Calderón Geraldine Genard Joana Filipa Guerreiro Francesco Saverio Costanzo Joao Seco |
author_sort |
Luca Tirinato |
title |
Lipid droplets and ferritin heavy chain: a devilish liaison in human cancer cell radioresistance |
title_short |
Lipid droplets and ferritin heavy chain: a devilish liaison in human cancer cell radioresistance |
title_full |
Lipid droplets and ferritin heavy chain: a devilish liaison in human cancer cell radioresistance |
title_fullStr |
Lipid droplets and ferritin heavy chain: a devilish liaison in human cancer cell radioresistance |
title_full_unstemmed |
Lipid droplets and ferritin heavy chain: a devilish liaison in human cancer cell radioresistance |
title_sort |
lipid droplets and ferritin heavy chain: a devilish liaison in human cancer cell radioresistance |
publisher |
eLife Sciences Publications Ltd |
series |
eLife |
issn |
2050-084X |
publishDate |
2021-09-01 |
description |
Although much progress has been made in cancer treatment, the molecular mechanisms underlying cancer radioresistance (RR) as well as the biological signatures of radioresistant cancer cells still need to be clarified. In this regard, we discovered that breast, bladder, lung, neuroglioma, and prostate 6 Gy X-ray resistant cancer cells were characterized by an increase of lipid droplet (LD) number and that the cells containing highest LDs showed the highest clonogenic potential after irradiation. Moreover, we observed that LD content was tightly connected with the iron metabolism and in particular with the presence of the ferritin heavy chain (FTH1). In fact, breast and lung cancer cells silenced for the FTH1 gene showed a reduction in the LD numbers and, by consequence, became radiosensitive. FTH1 overexpression as well as iron-chelating treatment by Deferoxamine were able to restore the LD amount and RR. Overall, these results provide evidence of a novel mechanism behind RR in which LDs and FTH1 are tightly connected to each other, a synergistic effect that might be worth deeply investigating in order to make cancer cells more radiosensitive and improve the efficacy of radiation treatments. |
topic |
lipid droplets radioresistance iron metabolism ferritin heavy chain cancer |
url |
https://elifesciences.org/articles/72943 |
work_keys_str_mv |
AT lucatirinato lipiddropletsandferritinheavychainadevilishliaisoninhumancancercellradioresistance AT mariagraziamarafioti lipiddropletsandferritinheavychainadevilishliaisoninhumancancercellradioresistance AT francescapagliari lipiddropletsandferritinheavychainadevilishliaisoninhumancancercellradioresistance AT jeannettejansen lipiddropletsandferritinheavychainadevilishliaisoninhumancancercellradioresistance AT ileniaaversa lipiddropletsandferritinheavychainadevilishliaisoninhumancancercellradioresistance AT rachelhanley lipiddropletsandferritinheavychainadevilishliaisoninhumancancercellradioresistance AT clelianistico lipiddropletsandferritinheavychainadevilishliaisoninhumancancercellradioresistance AT danielgarciacalderon lipiddropletsandferritinheavychainadevilishliaisoninhumancancercellradioresistance AT geraldinegenard lipiddropletsandferritinheavychainadevilishliaisoninhumancancercellradioresistance AT joanafilipaguerreiro lipiddropletsandferritinheavychainadevilishliaisoninhumancancercellradioresistance AT francescosaveriocostanzo lipiddropletsandferritinheavychainadevilishliaisoninhumancancercellradioresistance AT joaoseco lipiddropletsandferritinheavychainadevilishliaisoninhumancancercellradioresistance |
_version_ |
1716839499119460352 |
spelling |
doaj-875cfacd9fc346f3be09bad933aa12572021-10-07T09:26:24ZengeLife Sciences Publications LtdeLife2050-084X2021-09-011010.7554/eLife.72943Lipid droplets and ferritin heavy chain: a devilish liaison in human cancer cell radioresistanceLuca Tirinato0https://orcid.org/0000-0001-9826-2129Maria Grazia Marafioti1Francesca Pagliari2https://orcid.org/0000-0002-5547-222XJeannette Jansen3https://orcid.org/0000-0002-8625-3978Ilenia Aversa4Rachel Hanley5https://orcid.org/0000-0002-2627-1146Clelia Nisticò6https://orcid.org/0000-0002-0787-9527Daniel Garcia-Calderón7Geraldine Genard8https://orcid.org/0000-0002-9495-0335Joana Filipa Guerreiro9https://orcid.org/0000-0003-1960-603XFrancesco Saverio Costanzo10Joao Seco11https://orcid.org/0000-0002-9458-2202Biomedical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, Germany; Experimental and Clinical Medicine Department, University Magna Graecia of Catanzaro, Catanzaro, ItalyBiomedical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, Germany; Experimental and Clinical Medicine Department, University Magna Graecia of Catanzaro, Catanzaro, ItalyBiomedical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, GermanyBiomedical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, Germany; Department of Physics and Astronomy, Heidelberg University, Im Neuenheimer Feld, Heidelberg, GermanyBiomedical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, Germany; Experimental and Clinical Medicine Department, University Magna Graecia of Catanzaro, Catanzaro, ItalyBiomedical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, GermanyBiomedical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, Germany; Experimental and Clinical Medicine Department, University Magna Graecia of Catanzaro, Catanzaro, ItalyBiomedical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, Germany; Department of Physics and Astronomy, Heidelberg University, Im Neuenheimer Feld, Heidelberg, GermanyBiomedical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, GermanyCentro de Ciências e Tecnologias Nucleares, Instituto Superior Técnico, Universidade de Lisboa, Lisboa, PortugalExperimental and Clinical Medicine Department, University Magna Graecia of Catanzaro, Catanzaro, ItalyBiomedical Physics in Radiation Oncology, German Cancer Research Center (DKFZ), Im Neuenheimer Feld, Heidelberg, Germany; Department of Physics and Astronomy, Heidelberg University, Im Neuenheimer Feld, Heidelberg, GermanyAlthough much progress has been made in cancer treatment, the molecular mechanisms underlying cancer radioresistance (RR) as well as the biological signatures of radioresistant cancer cells still need to be clarified. In this regard, we discovered that breast, bladder, lung, neuroglioma, and prostate 6 Gy X-ray resistant cancer cells were characterized by an increase of lipid droplet (LD) number and that the cells containing highest LDs showed the highest clonogenic potential after irradiation. Moreover, we observed that LD content was tightly connected with the iron metabolism and in particular with the presence of the ferritin heavy chain (FTH1). In fact, breast and lung cancer cells silenced for the FTH1 gene showed a reduction in the LD numbers and, by consequence, became radiosensitive. FTH1 overexpression as well as iron-chelating treatment by Deferoxamine were able to restore the LD amount and RR. Overall, these results provide evidence of a novel mechanism behind RR in which LDs and FTH1 are tightly connected to each other, a synergistic effect that might be worth deeply investigating in order to make cancer cells more radiosensitive and improve the efficacy of radiation treatments.https://elifesciences.org/articles/72943lipid dropletsradioresistanceiron metabolismferritin heavy chaincancer |